VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
ALXO
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
ALXOALX Oncology Holdings Inc.
$2.19$119M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksALXOQuarterly Financials

ALX Oncology Holdings Inc. (ALXO) Quarterly Financials

120+ quarters historyFree accessUpdated daily

ALX Oncology Holdings Inc. (ALXO) quarterly income statement — complete revenue, gross profit & net income history

ALXO Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21Q2'21
Sales/Revenue00000000000000000000
Revenue Growth %--------------------100%
Cost of Goods Sold150K000000220K214K0000413K000000
COGS % of Revenue--------------------
Gross Profit-150K000000-220K-214K0000-413K000000
Gross Margin %--------------------
Gross Profit Growth %---100%100%----100%----------100%
Operating Expenses18.82M23.02M22.53M26.65M31.82M30.61M32.57M41.3M37.55M48.02M53.27M36.78M32.2M31.81M36.68M33.79M24.75M28.47M24.58M16.3M
OpEx % of Revenue--------------------
Selling, General & Admin5.36M5.38M5.09M5.45M7.93M7.08M6.1M6.65M5.83M6.24M7.51M7.29M7.44M6.61M7.3M7.04M7.67M7.58M6.36M5.09M
SG&A % of Revenue--------------------
Research & Development13.61M17.64M17.44M18.02M23.89M23.53M26.47M34.65M31.72M41.78M45.77M29.48M24.76M25.2M29.38M26.75M17.07M20.89M18.21M11.21M
R&D % of Revenue--------------------
Other Operating Expenses-150K001000K0000000000000000
Operating Income-18.97M-23.02M-22.53M-26.65M-31.82M-30.61M-32.57M-41.52M-37.76M-48.02M-53.27M-36.78M-32.2M-32.22M-36.68M-33.79M-24.75M-28.47M-24.58M-16.3M
Operating Margin %--------------------
Operating Income Growth %40.4%24.8%30.81%35.83%15.74%36.25%38.87%-12.91%-17.26%-49.05%-45.24%-8.84%-30.13%-13.16%-49.26%-107.31%-74.18%-59.73%-150.55%-51.1%
EBITDA-18.82M-22.87M-22.38M-26.46M-31.61M-30.4M-32.34M-41.3M-37.55M-47.82M-53.07M-36.57M-31.99M-32.11M-36.59M-33.7M-24.69M-28.44M-24.57M-16.29M
EBITDA Margin %--------------------
EBITDA Growth %40.47%24.77%30.81%35.95%15.82%36.43%39.05%-12.95%-17.37%-48.89%-45.04%-8.5%-29.57%-12.93%-48.91%-106.87%-73.83%-59.58%-150.61%-52.16%
D&A (Non-Cash Add-back)150K151K153K191K211K214K224K220K214K207K209K207K213K105K95K84K58K34K6K6K
EBIT-18.97M-22.46M-21.74M-25.54M-30.35M-28.74M-30.26M-38.97M-35.15M-45.06M-50.6M-33.79M-29.8M-32.22M-35.32M-32.92M-24.53M-28.46M-24.58M-16.3M
Net Interest Income851K190K394K701K1.08M1.45M1.86M2.13M2.19M2.58M2.29M2.29M1.92M1.81M1.37M874K222K-3K-4K-3K
Interest Income1.18M573K802K1.11M1.48M1.88M2.3M2.56M2.62M3M2.68M2.67M2.31M1.81M1.37M876K225K000
Interest Expense331K383K408K405K406K427K446K429K427K415K391K372K387K02K2K3K3K4K3K
Other Income/Expense1.04M173K388K699K1.07M1.45M1.86M2.13M2.18M2.55M2.29M2.62M2.02M1.57M1.36M869K214K13K10K25K
Pretax Income-17.93M-22.85M-22.14M-25.95M-30.75M-29.16M-30.71M-39.4M-35.58M-45.47M-50.99M-34.16M-30.18M-30.64M-35.32M-32.92M-24.53M-28.46M-24.57M-16.27M
Pretax Margin %--------------------
Income Tax000000000000064K000-21K00
Effective Tax Rate %0%0%0%0%0%0%0%0%0%0%0%0%0%-0.21%0%0%0%0.07%0%0%
Net Income-17.93M-22.85M-22.14M-25.95M-30.75M-29.16M-30.71M-39.4M-35.58M-45.47M-50.99M-34.16M-30.18M-30.71M-35.32M-32.92M-24.53M-28.44M-24.57M-16.27M
Net Margin %--------------------
Net Income Growth %41.71%21.65%27.89%34.14%13.57%35.87%39.78%-15.34%-17.88%-48.07%-44.37%-3.76%-23.03%-7.99%-43.78%-102.29%-72.95%-51.48%-141.29%-43.62%
Net Income (Continuing)-17.93M-22.85M-22.14M-25.95M-30.75M-29.16M-30.71M-39.4M-35.58M-45.47M-50.99M-34.16M-30.18M-30.71M-35.32M-32.92M-24.53M-28.44M-24.57M-16.27M
Discontinued Operations00000000000000000000
Minority Interest00000000000000000000
EPS (Diluted)-0.33-0.42-0.41-0.49-0.58-0.55-0.58-0.76-0.71-0.93-1.24-0.84-0.70-0.75-0.87-0.79-0.60-0.70-0.61-0.40
EPS Growth %43.1%23.64%29.31%35.53%18.31%40.86%53.23%9.52%-1.43%-24%-42.53%-6.33%-16.67%-7.14%-42.62%-97.5%-71.43%-40%-79.41%-21.21%
EPS (Basic)-0.33-0.42-0.41-0.49-0.58-0.55-0.58-0.76-0.71-0.93-1.24-0.84-0.70-0.75-0.87-0.79-0.60-0.70-0.61-0.40
Diluted Shares Outstanding54.28M54.28M53.58M53.45M53.36M52.8M52.69M51.83M50.12M49M41.15M40.88M40.86M40.76M40.75M40.69M40.62M40.53M40.4M40.25M
Basic Shares Outstanding54.28M54.28M53.58M53.45M53.36M52.8M52.69M51.83M50.12M49M41.15M40.88M40.86M40.76M40.75M40.69M40.62M40.53M40.4M40.25M
Dividend Payout Ratio--------------------